Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry.

Francesca PuggioniLuisa BrussinoGiorgio Walter CanonicaFrancesco BlasiPierluigi PaggiaroMarco CaminatiManuela LatorreEnrico HefflerGianenrico Sennanull null

Published in: Journal of asthma and allergy (2020)

TBR is still underused in severe asthma in a real-life setting, while a relevant proportion of patients are treated with other LAMA that are not approved for severe asthma treatment. Patients taking LAMA have features characteristic of even more severe asthma.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
patient reported outcomes
artificial intelligence
big data
drug administration